Abstract:Asthma, a chronic inflammatory disorder of the airways, is a prevalent childhood chronic disease with a substantial global health burden. The complex etiology and pathogenesis of asthma involve genetic and environmental factors, posing challenges in diagnosis, severity prediction, and therapeutic strategies. Recent studies have highlighted the significant role of the gut microbiota and its interaction with the immune system in the development of asthma. Dysbiosis, an imbalance in microbial composition, has been associated with respiratory diseases through the gut-lung axis. This axis is an interaction between the gut and lungs, allowing microbial metabolites to influence the host immune system. This systematic review examines the association between gut microbiota composition, measured using 16S rRNA sequencing, during infancy and childhood, and the subsequent development of atopic wheeze and asthma. The results suggest that higher alpha diversity of bacteria such as Bifidobacterium, Faecalibacterium, and Roseburia may have protective effects against asthmatic outcomes. Conversely, lower relative abundances of bacteria like Bacteroides and certain fungi, including Malassezia, were associated with asthma. These findings highlight the potential of early screening and risk assessment of gut microbiota to identify individuals at risk of asthma. Furthermore, investigations targeting gut microbiota, such as dietary modifications and probiotic supplementation, may hold promise for asthma prevention and management. Future research should focus on identifying specific microbial signatures associated with asthma susceptibility and further investigate approaches like fecal microbiota transplantation. Understanding the role of gut microbiota in asthma pathogenesis can contribute to early detection and development of interventions to mitigate the risk of asthmatic pathogenesis in childhood.

Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches

Gut‐lung axis and asthma: A historical review on mechanism and future perspective

The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches

Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis

Impact of gut microbiota on immune reactions relevant to lung pathologies

Gut microbiome a promising target for management of respiratory diseases

The gut microbiota modulates airway inflammation in allergic asthma through the gut-lung axis related immune modulation: A review

A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases

Gut microecological regulation on bronchiolitis and asthma in children: A review

Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics

Gut Mycobiome and Asthma

Link between gut microbiota dysbiosis and childhood asthma: Insights from a systematic review

Possible role of gut microbes and host’s immune response in gut–lung homeostasis

Microbes little helpers and suppliers for therapeutic asthma approaches

Human matters in asthma: Considering the microbiome in pulmonary health

Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma

Influence and effect of the human microbiome in allergy and asthma

Dysbiosis of the gut and lung microbiome has a role in asthma

The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases

Diet, Microbiota and Gut-Lung Connection

The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections